ArticleMetabolic brain disease2025
Exploring the effects of squalene in the PERK/ATF4/eIF2α/CHOP signalling pathway in an in vitro Alzheimer Disease model and in silico approach.
Bahar Sarikamis Johnson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it